Sale!

EUREPA V 0.5/03 TAB

Original price was: ₹155.00.Current price is: ₹139.50.

Eurepa V 0.5/03 Tablet is a medicine containing Repaglinide and Voglibose, commonly used for managing blood sugar levels in diabetic patients.

SKU: 68990 Categories: ,

Description

Eurepa V 0. 5/03 Tablet is a combination medicine that contains Repaglinide and Voglibose as active ingredients. Repaglinide is an oral antidiabetic drug that helps control blood sugar levels by stimulating the release of insulin from the pancreas. Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown and absorption of complex carbohydrates in the intestine, thus reducing postprandial glucose levels. This medicine is primarily used in the treatment of type 2 diabetes mellitus to control blood sugar levels. It helps regulate blood glucose spikes after meals by enhancing insulin release and slowing carbohydrate absorption. Eurepa V 0. 5/03 Tablet is usually prescribed in conjunction with a proper diet, regular exercise, and other antidiabetic medications to achieve optimal glycemic control. It is important to follow the dosage and frequency prescribed by your healthcare provider and regularly monitor your blood sugar levels while taking this medicine. Additionally, inform your doctor about any other medications or medical conditions you have to avoid potential drug interactions or complications.

Additional information

Marketed by

Composition

Dosage form

TABLET

Prescription

REQUIRED

Therapeutic use

ANTI DIABETICS

Note: The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.